X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (334) 334
humans (306) 306
hepatitis c (261) 261
hepatitis c virus (254) 254
antiviral agents - therapeutic use (220) 220
hepatitis c, chronic - drug therapy (215) 215
gastroenterology & hepatology (200) 200
hepacivirus - genetics (168) 168
ribavirin (161) 161
interferon (153) 153
hepatitis (151) 151
genotype (145) 145
drug therapy, combination (139) 139
sustained virological response (131) 131
hepacivirus - drug effects (130) 130
treatment-naive patients (124) 124
antiviral agents (122) 122
plus ribavirin (116) 116
health aspects (111) 111
male (108) 108
female (107) 107
hepatitis c, chronic - virology (99) 99
middle aged (97) 97
sofosbuvir (97) 97
daclatasvir plus asunaprevir (94) 94
daclatasvir (92) 92
biological response modifiers (91) 91
therapy (90) 90
genotype 1 infection (86) 86
pharmacology & pharmacy (85) 85
treatment outcome (83) 83
virus-infection (83) 83
cirrhosis (81) 81
aged (80) 80
hepatitis c - drug therapy (79) 79
liver (79) 79
antiviral agents - adverse effects (76) 76
hcv (76) 76
antiviral agents - administration & dosage (73) 73
infections (73) 73
patients (73) 73
pegylated interferon (72) 72
adult (70) 70
direct-acting antivirals (68) 68
ribavirin - therapeutic use (67) 67
genotype & phenotype (65) 65
asunaprevir (64) 64
genetic aspects (63) 63
liver cirrhosis (63) 63
care and treatment (62) 62
drug therapy (62) 62
protease inhibitors (62) 62
treatment-experienced patients (61) 61
infection (60) 60
sustained virologic response (59) 59
genotypes (57) 57
hepatology (57) 57
virus diseases (57) 57
telaprevir (56) 56
viruses (56) 56
antiviral agents - pharmacology (55) 55
virology (55) 55
analysis (54) 54
imidazoles - therapeutic use (53) 53
treatment-naive (53) 53
interferon-alpha - therapeutic use (52) 52
simeprevir (51) 51
medicine & public health (48) 48
sofosbuvir plus ribavirin (47) 47
drug resistance, viral (46) 46
infectious diseases (46) 46
open-label (46) 46
peginterferon alpha-2a (45) 45
gastroenterology and hepatology (43) 43
protease inhibitor (43) 43
combination therapy (42) 42
hepatitis c, chronic - complications (42) 42
medical research (41) 41
sulfonamides - therapeutic use (41) 41
chronic hepatitis c (40) 40
liver diseases (40) 40
chronic hepatitis-c (39) 39
gastroenterology (39) 39
ledipasvir (39) 39
efficacy (38) 38
hcv genotype 1 (38) 38
hepatocellular-carcinoma (38) 38
drug resistance (37) 37
hepatitis-c virus (37) 37
medicine, experimental (37) 37
plus asunaprevir (37) 37
proteases (37) 37
hcv infection (36) 36
imidazoles - administration & dosage (36) 36
medicine, general & internal (36) 36
ns5a inhibitor (36) 36
safety (36) 36
viral nonstructural proteins - antagonists & inhibitors (36) 36
chronic infection (35) 35
genotype 1 (35) 35
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA - Journal of the American Medical Association, ISSN 0098-7484, 05/2015, Volume 313, Issue 17, pp. 1728 - 1735
Journal Article
Hepatology, ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 742 - 748
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 655 - 662
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 09/2015, Volume 104, Issue 9, pp. 2813 - 2823
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 04/2019, Volume 59, Issue 4, pp. 557 - 565
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 05/2015, Volume 313, Issue 17, pp. 1736 - 1744
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 2, pp. 420 - 429
Journal Article
Liver International, ISSN 1478-3223, 09/2017, Volume 37, Issue 9, pp. 1325 - 1333
Journal Article
Hepatology Research, ISSN 1386-6346, 10/2017, Volume 47, Issue 11, pp. 1127 - 1136
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 12/2017, Volume 32, Issue 12, pp. 1998 - 2005
Journal Article